REVOLAX FineIn Stock

Effect of procedure 

─

REVOLAX Fine Lidocaine is designed for the treatment of superficial wrinkles, including crow's feet, frown lines, and neck wrinkles. It penetrates quickly into the skin, creating a very natural and healthier look for the injected area.

Treatment of superficial wrinkles

Facial Volumeizing

Applied Area

─

• Superficial lines

• Crow’s Feet

• Neck Wrinkles

• Frown lines

Recommended Treatment Policy

─

• Needle : 30G

• Injection depth : Superficial to top dermis

Specifications

─

• Type : Monophasic

• Ingredients : Hyaluronic acid, Lidocaine

• HA Composition : 24mg/ml

• Lidocaine : 0.3%

• Complex Viscosity : 80

• Aesthetic effect : 8 – 12 Months

• Packaging : 1.1ml syringe / 2 needles

• Storage : 2~25˚C

Features

─

High Purity

REVOLAX™ is bio-degradable gel that uses hyaluronic acid with high purity from bacterial fermentation. It is natural substance optimized to suit with human skin tissue.

Optimal Crosslinked HA

Our unique cross linking technology does not need adding free Hyaluronic acid to adjust physical property of the gel.

Visco-elasticity

Visco-elasticity is one of the most critical elements that determine longevity. Volume effect and molding ability of the gel has been optimized by level of visco-elasticity per product according to use and treatment area. REVOLAX™ makes sure longer lasting and stronger support for skin structure.

Consistent Monophasic

REVOLAX™ is made of regular and dense monophasic structure. The consistency of the pattern ensures not only naturally harmonized volume but easy and comfortable injection for both surgeons and patients.

Description

─

Soft Injection

- By using Ultra Thin Wall needle, soft injection is available and helpful to minimize pop off.

- Due to uniform monophasic structure, REVOLAX™ can be properly injected without free HA.

Extrusion Force Test Graph

** Ref. Data on file. Across

** Injection should be taking not just less force but consistent force as well.

Clinical Study

Efficacy and Safety of REVOLAX™™ Sub-Q with Lidocaine-Clinical Study Result (NCT02179606)

Study Design

Multi-Center, Randomized, Subject and Evaluator Blind, Split-Face, Comparative (24-Weeks)

Subjects

60 Subjects with confirmed WSRS(Wrinkle Severity Rating Scale) Grade 3 or 4 nasolabial folds who want correction

Comparison of the means of WSRS* in Week 24

Evaluation of the overall aesthetic results by the investigators and the subjects (Calculated from GAIS)

Result: Mean WSRS* scores assessed at week 24 of REVOLAX are lower than those of A filler group. *The Wrinkle Severity Rating Scale(WSRS)

Result: Both investigators and subjects were satisfied highly with the effect of the REVOLAX "group for 6months. *Global Aesthetic Improvement Scale. (GAIS)